Efficacy and Safety Study of Seroquel SR in the treatment of Major Depressive Disorder

Study identifier:D1448C00014

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR) in the Treatment of Elderly Patients with Major Depressive Disorder

Medical condition

Major depressive disorder

Phase

Phase 3

Healthy volunteers

No

Study drug

Quetiapine

Sex

All

Actual Enrollment

338

Study type

Interventional

Age

66 Years +

Date

Study Start Date: 01 Sept 2006
Primary Completion Date: 01 Dec 2007
Study Completion Date: 01 Dec 2007

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria